Form D · Biotechnology

Dianomi Therapeutics, Inc.

Madison, WI · CIK 0001737087

Offering snapshot reported Jan 25, 2019 · SEC filing

Reported sold
$185K
Offering amount: $2M
Investors reported
5
Form D · investor count
Minimum accepted
$10K
Reported outside-investor minimum
First sale
Mar 30, 2018
As reported in this filing

Fundraising history

Reported sold
Reported amount sold by Form D filing date$0$92.5K$185KApr 11, 2018: $185,000.00Apr 11, 2018Jan 25, 2019: $185,000.00Jan 25, 2019

Dates are filing dates, not cash receipt dates. Decreases are reported revisions, not evidence of withdrawals. Separate offering histories are not added together.

What changed?

Latest filing versus its linked predecessor, where available.

  • Minimum accepted$100,000 → $10,000

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 25, 2019Amendment$185,000$0vs Apr 11, 20185SEC filing
Apr 11, 2018Initial$185,000No comparison5SEC filing

Offering details

Securities
Debt
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-309836

Source: Form D, filed Jan 25, 2019. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Carter Cliff Director, Executive
Kurtis Knapp Director, Executive
Barry Kurokawa Director, Executive
William Murphy Director, Executive

Issuer details

Industry: Biotechnology (See others in industry)

Address:
504 South Rosa Road
Madison, WI, 53719